Navigation Links
JHP Pharmaceuticals Enters Agreement to Produce Diagnostic Aid
Date:10/18/2011

PARSIPPANY, N.J., Oct. 18, 2011 /PRNewswire/ -- JHP Pharmaceuticals, a provider of global contract manufacturing services for sterile injectable products announced today that it has entered into an agreement with an undisclosed pharmaceutical company for the product transfer and registration batch production of a diagnostic aid.

Stuart Hinchen, president and CEO of JHP stated "Our record of cGMP compliance, coupled with comprehensive experience in manufacturing site transfers put us in the position to serve this important customer."

Commenting on the successful completion of recent FDA and EMA audits in addition to agreements with six new customers, Hinchen noted, "Our Rochester, Michigan site has a 25 year history in contract manufacturing. This accomplishment was created by a quality-driven, experienced staff and a customer-centric approach. Since purchasing the plant in 2007, we have focused on growing our internal infrastructure to support expansion of our contract manufacturing services by investing in both our people and our facilities. Recent investments include a clinical filler and a 240 sq. ft. lyophilizer in addition to expanding our Manufacturing, Regulatory and Quality Teams."

"JHP Pharmaceuticals has extensive experience working with products throughout their life cycle starting with clinical trial supplies, through regulatory approval, product launch and global commercialization providing customers with the right scale and experience to meet their product life cycle needs."

About JHP Pharmaceuticals, LLC

JHP Pharmaceuticals, headquartered in New Jersey, provides contract manufacturing of sterile injectables, biologics, vaccines, ophthalmics and otics for large and small pharmaceutical and biotech organizations. JHP's sterile manufacturing facility, located in Rochester Michigan sits on over 80 acres of land and includes a 171,000 sq. ft. production building and warehouse. The production facility utilizes three high-speed filling lines, four lyophilizers and a clinical fill line. The site also includes separate facilities for chemistry, sterility testing, and analytical methods development.

JHP has the capability to manufacture small-scale clinical through large-scale commercial products. JHP employs more than 330 staff in the USA in its manufacturing, product development, regulatory, sales & marketing and corporate areas. For more information, please visit www.jhppharma.com.

Contact:
Dan Leone
973.658.3559

Bill Conway
877.906.7556

jhpcontractservices@jhppharma.com

MK265


'/>"/>
SOURCE JHP Pharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Par Pharmaceutical Acquires Three Generic Products From Teva Pharmaceuticals
2. Ampio Pharmaceuticals Announces a Proof of Concept Trial of Danazol in the Treatment of Allergic Rhinitis Supports Mechanism of Action of Optina™
3. Pacira Pharmaceuticals, Inc. Announces Key EXPAREL™ Data to be Presented at American College of Surgeons 97th Annual Clinical Congress
4. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Anadys Pharmaceuticals Inc. in Connection with the Sale of the Company to Roche Holding AG
5. Auxilium Pharmaceuticals to Announce Third Quarter 2011 Results and Conduct Conference Call on Monday, October 31, 2011
6. Reata Pharmaceuticals Adds Executives to Management Team and Board of Directors
7. Access Pharmaceuticals Updates MuGard Website with New Video Featuring Clinical Feedback and Manufacturing Footage
8. Cumberland Pharmaceuticals to Announce Third Quarter 2011 Financial Results on November 3, 2011
9. Avanir Pharmaceuticals to Present Data at the 2011 American Congress of Rehabilitation Medicine/American Society for Neurorehabilitation Medicine Annual Conference
10. Amylin Pharmaceuticals to Webcast Third Quarter Results
11. Cumberland Pharmaceuticals Appoints Rick S. Greene Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... Dublin - ... " Global Markets for Spectroscopy Equipment" report ... This report focuses on the global market of ... applications in various applications. The report deals with spectroscopy ... industries: pharmaceutical and biotechnology, food and beverage, and environmental ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy ... in the United States and Canada wear eyeglasses. Once considered to be a purely ... make a fashion statement. Even celebrities use glasses as a way of creating an ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
Breaking Medicine News(10 mins):